Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Non-Current Deffered Revenue (2016 - 2017)

Amphastar Pharmaceuticals has reported Non-Current Deffered Revenue over the past 5 years, most recently at $1.2 million for Q3 2017.

  • For Q3 2017, Non-Current Deffered Revenue rose 623.21% year-over-year to $1.2 million; the TTM value through Sep 2017 reached $1.2 million, up 623.21%, while the annual FY2016 figure was $97000.0, 92.76% down from the prior year.
  • Non-Current Deffered Revenue for Q3 2017 was $1.2 million at Amphastar Pharmaceuticals, up from $423000.0 in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $2.6 million in Q4 2013 and troughed at $97000.0 in Q4 2016.
  • A 5-year average of $1.3 million and a median of $1.3 million in 2015 define the central range for Non-Current Deffered Revenue.
  • Biggest five-year swings in Non-Current Deffered Revenue: tumbled 92.76% in 2016 and later soared 623.21% in 2017.
  • Year by year, Non-Current Deffered Revenue stood at $2.6 million in 2013, then decreased by 24.5% to $2.0 million in 2014, then crashed by 32.44% to $1.3 million in 2015, then tumbled by 92.76% to $97000.0 in 2016, then soared by 1152.58% to $1.2 million in 2017.
  • Business Quant data shows Non-Current Deffered Revenue for AMPH at $1.2 million in Q3 2017, $423000.0 in Q2 2017, and $280000.0 in Q1 2017.